In addition, IL-6/STAT3 signaling pathway activation mediated thrombopoietin (TPO) production (36), elevated TPO levels are also detected in patients with COVID-19 (37) and TPO is known to promote platelet production. This evidence concerns the gene IL6 and COVID-19.